Relmada Therapeutics, Inc. (NASDAQ:RLMD) Given Consensus Recommendation of Hold by Brokerages

Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month […]

Related Keywords

Chicago ,Illinois ,United States ,Cedric Ogorman ,Advisorshares Investments ,Parsons Capital Management Inc ,Capital Partners ,Nasdaq ,Relmada Therapeutics Inc ,Chicago Partners Investment Group ,Guild Investment Management Inc ,Relmada Therapeutics ,Get Free Report ,Marketbeat Ratings ,Cedrico Gorman ,Partners Investment Group ,Shares Investments ,Investment Management ,Parsons Capital Management ,Capital Management ,Therapeutics Trading Down ,Get Free ,Relmada Therapeutics Daily ,Nasdaq Rlmd ,Rlmd ,Medical ,Ratings ,Consensus ,